These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 25651905)
1. Emerging biologics for the treatment of chronic rhinosinusitis. Pauwels B; Jonstam K; Bachert C Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905 [TBL] [Abstract][Full Text] [Related]
2. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps]. Chen YJ; Chai XB Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221 [TBL] [Abstract][Full Text] [Related]
3. Biologics in Chronic Rhinosinusitis: Current and Emerging. Boyd JT; Khanwalkar AR Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716 [TBL] [Abstract][Full Text] [Related]
4. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps. Bachert C; Gevaert P; Hellings P J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278 [TBL] [Abstract][Full Text] [Related]
5. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps. Lee M; Kim DW; Shin HW Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy in sinonasal disease. Chiarella SE; Sy H; Peters AT Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440 [TBL] [Abstract][Full Text] [Related]
7. Chronic Rhinosinusitis-Could Phenotyping or Endotyping Aid Therapy? Bayar Muluk N; Cingi C; Scadding GK; Scadding G Am J Rhinol Allergy; 2019 Jan; 33(1):83-93. PubMed ID: 30353741 [TBL] [Abstract][Full Text] [Related]
8. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis. Licari A; Castagnoli R; De Filippo M; Foiadelli T; Tosca MA; Marseglia GL; Ciprandi G Expert Opin Biol Ther; 2020 Jun; 20(6):609-619. PubMed ID: 32053391 [No Abstract] [Full Text] [Related]
9. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094 [TBL] [Abstract][Full Text] [Related]
10. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps. Kartush AG; Schumacher JK; Shah R; Patadia MO Am J Rhinol Allergy; 2019 Mar; 33(2):203-211. PubMed ID: 30587005 [TBL] [Abstract][Full Text] [Related]
11. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083 [TBL] [Abstract][Full Text] [Related]
12. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies. Kariyawasam HH Expert Rev Clin Immunol; 2019 Jan; 15(1):59-71. PubMed ID: 30370785 [No Abstract] [Full Text] [Related]
13. A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps. Codispoti CD; Mahdavinia M Ann Allergy Asthma Immunol; 2019 Sep; 123(3):232-239. PubMed ID: 31295554 [TBL] [Abstract][Full Text] [Related]
14. The Role of Biologics in the Treatment of Nasal Polyps. Franzese CB Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452 [TBL] [Abstract][Full Text] [Related]
15. Use of biologics in chronic sinusitis with nasal polyps. Wang C; Zhang L Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822 [TBL] [Abstract][Full Text] [Related]
16. Phenotypes of Chronic Rhinosinusitis. Cho SH; Hamilos DL; Han DH; Laidlaw TM J Allergy Clin Immunol Pract; 2020 May; 8(5):1505-1511. PubMed ID: 32389275 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives. Okano M; Kanai K; Oka A Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131 [TBL] [Abstract][Full Text] [Related]
18. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations. Li N; Peters AT Allergy Asthma Proc; 2015; 36(5):339-43. PubMed ID: 26314815 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739 [TBL] [Abstract][Full Text] [Related]
20. An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma. Castagnoli R; Licari A; Brambilla I; Tosca M; Ciprandi G; Marseglia GL Expert Rev Respir Med; 2020 Dec; 14(12):1197-1205. PubMed ID: 32875924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]